An experience of hyperbaric oxygen and transurethral coagulation combination therapy for abnormal vessels and intractable macrohematuria due to pelvic arteriovenous malformations

Seiya Inoue, Masashi Honda, Shinji Hirano, Noriya Yamaguchi, Bunya Kawamoto, Tsounapi Panagiota, Katsuya Hikita, Kuniyasu Muraoka, Takehiro Sejima, Chihiro Takahashi, Atsushi Takenaka

Department of Urology, National Hospital Organization, Yonago Medical Center, Yonago, Japan.
Department of Urology, National Hospital Organization, Yonago Medical Center, Yonago, Japan; of Urology, Tottori University School of Medicine, Yonago, Japan;.
Department of Urology, Tottori University School of Medicine, Yonago, Japan.
Department of Urology, Tottori University School of Medicine, Yonago, Japan;.

DOI: 10.4236/crcm.2013.27106                

Abstract

A 78-year-old man was admitted to our hospital with a chief complaint of gross hematuria. The patient was diagnosed with pelvic arteriovenous malformations and repeated arterial embolization. A cystoscopy demonstrated that bladder trigone was covered by many clots. At the same time, bleeding mucosa at the right side of the bladder dome was confirmed. We administered hyperbaric oxygen therapy 7 days after admission. Macrohematuria recovered gradually and we then performed transurethral coagulation at the dome with failed mucosa 14 days after admission. Macrohematuria recovered completely and there was no recurrence during hospitalization. Thirty days after admission, we performed cystoscopy and found clear mucosa in the trigone. The patient was discharged 32 days after admission.

Keywords

Hyperbaric Oxygen Therapy; Macrohematuria; Pelvic Arteriovenous Malformations; Transurethral Coagulation

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Game, X., Berlizot, P., Hassan, T., Joffre, F., Chokairi, S., Houlgatte, A. and Rischmann, P. (2002) Congenital pelvic arteriovenous malformation in male patients: A rare case of urological symptoms and role of embolization. European Urology, 42, 407-412. http://dx.doi.org/10.1016/S0302-2838(02)00355-X
[2]	Rosenberg, J., Golimbu, M., Suarez, J. and Morales, P. (1973) Congenital arteriovenous malformation of the bladder. Journal of Urology, 109, 605-608.
[3]	Jacobowitz, G.R., Rosen, R.J., Rockman, C.B., Nalbandian, M., Hofstee, D.J., Fioole, B., Adelman, M.A., Lamparello, P.J., Gagne, P. and Riles, T.S. (2001) Transcatherter embolization of complex pelvic vascular malformations: Results and long-term follow-up. Journal of Vascular Surgery, 33, 51-55.
[4]	Nakada, T., Sasagawa, I., Koike, H., Furuta, T., Katayama, K., Ota, K., Chikenji, M., Matsushita, T. and Saito, H. (1989) Effect of hyperbaric oxygen therapy on essential haematuria. International Urology and Nephrology, 21, 3-8.
[5]	Mogelson, S., Davidson, J., Sobel, B.E. and Roberts, R. (1981) The effect of hyperbaric oxygen on infarct size in the conscious animal. European Journal of Cardiology, 12, 135-146.
[6]	Sumida, S. and Yagi, H. (1981) Experimental study on the inhibition of kinin release in endotoxin shock by glutathione, proteinase inhibitors, hydrocortisone and hyperbaric oxygen. Japanese Circulation Journal, 45, 1364-1368.
[7]	Hader, J.E., Marzella, L., Myers, R.A., Jacobs, S.C. and Naslund, M.J. (1993) Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis. Journal of Urology, 149, 1617-1621.
[8]	Capelli-Schellpferffer, M. and Gerber, G.S. (1999) The use of hyperbaric oxygen in urology. Journal of Urology, 162, 647-654.